Gynecological Disorders Practice Questions

Q: A young female presents with cyclical pain, dysmenorrhea, and infertility. Which of the following would be the investigation of choice in her?

Diagnostic laparoscopy. **Explanation:** The clinical triad of **cyclical pelvic pain, secondary dysmenorrhea, and infertility** in a young female is a classic presentation of **Endometriosis**. **1. Why Diagnostic Laparoscopy is the Correct Answer:** Diagnostic laparoscopy is considered the **"Gold Standard"** investigation for endometriosis. It allows for direct visualization of ectopic endometrial implants (e.g., powder-burn lesions, mulberry spots, or chocolate cysts) and provides the opportunity for simultaneous biopsy for histopathological confirmation. It is the only definitive way to diagnose early-stage or peritoneal endometriosis that imaging often misses. **2. Why Other Options are Incorrect:** * **Transvaginal Sonography (TVS):** While TVS is the investigation of choice for detecting an **Endometrioma** (chocolate cyst of the ovary), it has very low sensitivity for diagnosing peritoneal implants or adhesions. Therefore, it is not the definitive investigation of choice for overall endometriosis. * **Aspirate from Pouch of Douglas:** This is typically used to check for hemoperitoneum (e.g., ruptured ectopic pregnancy) or to obtain cytology in suspected malignancy. It is not a standard diagnostic tool for endometriosis. * **Hormonal Assessment:** Endometriosis is an estrogen-dependent condition, but there are no specific hormonal markers used to diagnose it. **Clinical Pearls for NEET-PG:** * **Gold Standard:** Laparoscopy + Biopsy. * **Most common site:** Ovary. * **CA-125:** May be elevated in endometriosis but is non-specific; used primarily for monitoring recurrence rather than diagnosis. * **Staging:** The American Society for Reproductive Medicine (ASRM) staging is based on laparoscopic findings. * **Management:** For infertility in endometriosis, the first-line treatment is often laparoscopic ablation/excision of lesions.

Q: Which type of uterine fibroid is most likely to cause pressure symptoms?

Subserous fibroid. **Explanation:** The clinical presentation of uterine fibroids (leiomyomas) is primarily determined by their **anatomical location** rather than just their size. **Why Subserous Fibroid is Correct:** Subserous fibroids are located just beneath the serosa and grow outward into the peritoneal cavity. Because they have space to expand away from the uterine cavity, they often reach a **massive size** before becoming symptomatic. Their large volume and external position allow them to exert direct mechanical pressure on adjacent pelvic organs. Common pressure symptoms include: * **Bladder:** Urinary frequency, urgency, or retention. * **Rectum:** Constipation or tenesmus. * **Pelvic Vessels:** Edema or varicose veins in the lower limbs. **Analysis of Incorrect Options:** * **Submucous Fibroid (A):** These grow just beneath the endometrium and distort the uterine cavity. Even when very small, they typically present with **menorrhagia** (heavy menstrual bleeding) or infertility. They rarely grow large enough to cause pressure symptoms because their clinical symptoms (bleeding) lead to earlier diagnosis and intervention. * **Options C & D:** These are incorrect as the physiological impact of fibroids is highly specific to their location. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Symptom of Fibroids:** Menorrhagia (especially in intramural and submucous types). * **Most Common Type of Fibroid:** Intramural. * **Fibroid most likely to undergo torsion:** Pedunculated subserous fibroid (presents as acute abdomen). * **Degeneration during pregnancy:** Red degeneration (due to rapid growth and venous obstruction). * **Best Initial Investigation:** Transvaginal Ultrasound (TVUS).

Q: Which of the following statements is true regarding benign ovarian tumors?

The capsule is intact.. **Explanation:** In gynecological oncology, distinguishing between benign and malignant ovarian masses is crucial for surgical planning. **1. Why the Correct Answer is Right:** The hallmark of a **benign ovarian tumor** is that it remains confined within its anatomical boundaries. The **capsule is intact**, and there is no surface excrescence or extracapsular growth. This lack of capsular penetration is a key diagnostic feature that differentiates it from malignant tumors, which often exhibit capsular breach and seeding into the peritoneal cavity. **2. Analysis of Incorrect Options:** * **A. Torsion is uncommon:** This is incorrect. Torsion is actually the **most common complication** of benign ovarian tumors (especially dermoid cysts). Because benign tumors are often mobile and pedunculated, they are highly prone to twisting on their pedicle. * **C. Ascites can occur:** While Meigs' Syndrome (fibroma + ascites + hydrothorax) is a rare exception, ascites is generally a **strong indicator of malignancy**. In benign cases, the peritoneal lining remains uninvolved, so fluid accumulation is typically absent. * **D. Size is typically less than 10 cm:** This is incorrect. Benign tumors, particularly **Mucinous Cystadenomas**, can reach massive sizes (sometimes filling the entire abdomen) without showing any signs of malignancy. **NEET-PG High-Yield Pearls:** * **Most common benign tumor:** Serous Cystadenoma (overall); Dermoid cyst (in women <30 years). * **IOTA Rules:** Benign tumors are characterized by unilocular cysts, presence of acoustic shadows, and no blood flow on Doppler (Color Score 1). * **Meigs' Syndrome:** A triad of Benign Ovarian Fibroma, Ascites, and Right-sided Pleural Effusion that resolves after tumor removal.

Q: What is the prevalence of malignancy in uterine fibroids?

0.50%. **Explanation:** Uterine fibroids (leiomyomas) are the most common benign tumors of the female reproductive tract. The correct prevalence of malignancy—specifically the transformation into **leiomyosarcoma**—is approximately **0.50%** (often cited in literature as ranging between 0.1% and 0.5%). This low risk is a critical clinical factor when deciding between conservative management and surgical intervention. * **Option A (0.50%) is correct:** Large-scale epidemiological studies and histopathological reviews confirm that the risk of an incidental leiomyosarcoma in a presumed fibroid is extremely low, typically around 1 in 200 to 1 in 400 cases. * **Options B, C, and D are incorrect:** These values (1%, 5%, and 10%) significantly overestimate the risk. If the malignancy rate were as high as 1% or more, conservative management (watchful waiting) would be clinically unjustifiable, and routine screening for malignancy in all fibroids would be mandatory. **High-Yield Clinical Pearls for NEET-PG:** 1. **Transformation:** Leiomyosarcomas are generally thought to arise *de novo* rather than from the malignant transformation of a pre-existing benign leiomyoma. 2. **Red Flags:** Rapid growth of a "fibroid," especially in **postmenopausal women**, is a significant warning sign for leiomyosarcoma. 3. **Diagnosis:** Definitive diagnosis of malignancy cannot be made via ultrasound or MRI; it requires **histopathological examination** (looking for cellular atypia, high mitotic index, and coagulative tumor necrosis). 4. **Management:** In perimenopausal women with rapidly enlarging masses, total hysterectomy is preferred over myomectomy to avoid morcellation, which can spread malignant cells if a sarcoma is present.

Q: Pyometra is a complication associated with all of the following conditions except:

Carcinoma of the vulva. **Explanation:** **Pyometra** refers to the accumulation of pus within the uterine cavity. The fundamental pathophysiology involves an **obstruction of the cervical canal**, which prevents the natural drainage of uterine secretions, leading to secondary infection and suppuration. **Why Carcinoma of the Vulva is the Correct Answer:** Carcinoma of the vulva is a malignancy of the external female genitalia. Because it is located externally and does not involve the cervix or the endocervical canal, it does not cause an anatomical obstruction to the uterine outflow tract. Therefore, it is not a recognized cause of pyometra. **Analysis of Other Options:** * **Carcinoma of the Cervix:** This is the most common cause of pyometra. The tumor growth can physically occlude the cervical os, or the subsequent fibrosis can lead to stenosis. * **Carcinoma of the Endometrium:** Large endometrial growths can prolapse into or block the internal os. Additionally, secondary infection of necrotic tumor tissue within the cavity often leads to pus formation. * **Pelvic Radiotherapy:** Radiation therapy for pelvic malignancies (like cervical cancer) often results in **endarteritis obliterans** and significant scarring/fibrosis of the cervical canal, leading to acquired cervical stenosis and subsequent pyometra. **NEET-PG High-Yield Pearls:** * **Most common cause:** Malignancy of the cervix or endometrium. * **Benign causes:** Senile atrophy (postmenopausal), cervical fibroids, or complications from procedures like cone biopsy or thermal ablation. * **Clinical Presentation:** Often asymptomatic, but may present with "blood-stained" purulent vaginal discharge and an enlarged, tender uterus. * **Management:** Dilatation of the cervix and drainage of pus. **Crucial Step:** Always perform a fractional curettage or endometrial biopsy after drainage to rule out underlying malignancy.

Q: A woman presents with a histopathology report of endometrial hyperplasia. Which of the following ovarian lesions is NOT a potential cause?

Fibroid. **Explanation:** The core medical concept behind endometrial hyperplasia is **unopposed estrogenic stimulation**. Any ovarian lesion that produces excess estrogen can lead to the proliferation of the endometrial lining. **Why Fibroid is the correct answer:** A **Fibroid (Leiomyoma)** is a benign monoclonal tumor of the uterine smooth muscle (myometrium). While fibroids are estrogen-dependent for their growth, they **do not produce estrogen** themselves. Therefore, a fibroid is a *result* of a high-estrogen state or local growth factors, but it is not a *cause* of endometrial hyperplasia. **Analysis of incorrect options:** * **Thecoma:** These are functional sex cord-stromal tumors composed of theca cells which actively secrete estrogen. They are frequently associated with endometrial hyperplasia and even endometrial carcinoma. * **Brenner Tumor:** While usually benign and fibroepithelial, approximately 10–15% of Brenner tumors have an active "thecomatous" stromal component that produces estrogen, potentially leading to endometrial changes. * **Follicular Cyst:** These are the most common functional cysts. They occur when a follicle fails to rupture and continues to grow, secreting excessive amounts of estrogen and causing anovulation. **NEET-PG High-Yield Pearls:** * **Most common ovarian tumor associated with endometrial hyperplasia:** Granulosa cell tumor (due to high inhibin and estrogen secretion). * **PCOS connection:** Polycystic Ovarian Syndrome is a classic cause of hyperplasia due to chronic anovulation and peripheral conversion of androgens to estrone. * **Thecoma vs. Fibroma:** Thecomas are estrogenic; Fibromas (associated with Meigs’ Syndrome) are usually non-functional.

Q: A 29-year-old nulliparous woman complains of severe menorrhagia and lower abdominal pain for the past 3 months. On examination, her uterus is enlarged to 14 weeks' size with a fundal fibroid. What is the treatment of choice?

Myomectomy. **Explanation:** The patient is a **29-year-old nulliparous woman** presenting with symptomatic uterine fibroids (menorrhagia and pain). In gynecological management, the choice of treatment is dictated primarily by the patient's age, symptoms, and desire for future fertility. **1. Why Myomectomy is the Correct Answer:** For a young woman who is nulliparous (desires to preserve fertility), **Myomectomy** is the surgical treatment of choice. It involves the removal of the fibroids while preserving the uterus. Since her uterus is significantly enlarged (14 weeks' size) and she is symptomatic, surgical intervention is indicated over medical management. **2. Why the Other Options are Incorrect:** * **GnRH Analogues:** These are generally used as a preoperative adjunct to shrink the size of the fibroid and reduce vascularity. They are not a definitive treatment as the fibroids typically regrow once the medication is discontinued. * **Hysterectomy:** This is the definitive treatment for fibroids but is reserved for women who have completed their family or are perimenopausal/postmenopausal. Performing a hysterectomy on a 29-year-old nulliparous woman is contraindicated unless there is a life-threatening malignancy. * **Wait and Watch:** This is only appropriate for asymptomatic fibroids. This patient is experiencing severe menorrhagia and pain, necessitating active treatment. **Clinical Pearls for NEET-PG:** * **Most common symptom of fibroid:** Menorrhagia (specifically for intramural and submucosal types). * **Most common degeneration:** Hyaline degeneration. * **Degeneration during pregnancy:** Red degeneration (due to rapid growth and venous thrombosis). * **Medical Management:** Ulipristal acetate (selective progesterone receptor modulator) or GnRH analogues can be used to reduce size pre-surgery. * **Surgical Rule:** If the uterus is >12 weeks in size or symptoms are severe, surgery is usually indicated.

Q: Decreased vascularity of fibroid is seen with which of the following medications?

Clomiphene citrate. **Explanation:** **Correct Option: D. Clomiphene citrate** Clomiphene citrate is a Selective Estrogen Receptor Modulator (SERM). While it is primarily used for ovulation induction, its anti-estrogenic effect on the myometrium leads to a significant **reduction in uterine artery blood flow and decreased vascularity** of uterine fibroids. This property is sometimes utilized preoperatively to minimize blood loss during myomectomy. **Analysis of Incorrect Options:** * **A. GnRH Agonists (e.g., Leuprolide):** These are the gold standard for preoperative medical management. They induce a hypoestrogenic state that **shrinks the size** of the fibroid (by ~30-50%) and reduces overall uterine volume. While they reduce blood flow, Clomiphene is specifically noted in literature for the most distinct decrease in vascularity indices. * **B. Danazol:** An androgenic steroid that creates a high-androgen, low-estrogen environment. It may shrink fibroids slightly and control symptoms like menorrhagia, but it is not the primary agent associated with decreased vascularity. * **C. Mifepristone:** A Selective Progesterone Receptor Modulator (SPRM). Since fibroids are progesterone-dependent, Mifepristone reduces their size and causes amenorrhea, but its primary mechanism is not the direct reduction of vascularity. **High-Yield Clinical Pearls for NEET-PG:** * **Medical Management Goal:** The primary goal of preoperative medical therapy (GnRH agonists) is to correct anemia and reduce fibroid volume. * **Red Degeneration:** The most common complication of fibroids during pregnancy (usually in the 2nd trimester) due to rapid growth and outstripping of blood supply. * **Hyaline Degeneration:** The most common type of degeneration overall. * **Uterine Artery Embolization (UAE):** A non-surgical procedure specifically designed to decrease vascularity and cause ischemic necrosis of the fibroid.

Question 1

A young female presents with cyclical pain, dysmenorrhea, and infertility. Which of the following would be the investigation of choice in her?

Accepted Answer

Diagnostic laparoscopy

Answer

Transvaginal sonography (TVS)

Answer

Aspirate from pouch of Douglas

Answer

Hormonal assessment

Question 2

Which type of uterine fibroid is most likely to cause pressure symptoms?

Accepted Answer

Subserous fibroid

Answer

Submucous fibroid

Answer

Both submucous and subserous fibroids

Answer

Neither submucous nor subserous fibroids

Question 3

Regarding a unicornuate uterus, which statement is true?

Accepted Answer

One Müllerian duct is completely absent

Answer

A defect in the fusion of Müllerian ducts

Answer

A single uterus with two fallopian tubes

Answer

Associated with the best reproductive outcome

Question 4

Which of the following statements is true regarding benign ovarian tumors?

Accepted Answer

The capsule is intact.

Answer

Torsion is uncommon.

Answer

Ascites can occur.

Answer

The size is typically less than 10 cm.

Question 5

What is the prevalence of malignancy in uterine fibroids?

Accepted Answer

0.50%

Answer

1%

Answer

5%

Answer

10%

Question 6

Pyometra is a complication associated with all of the following conditions except:

Accepted Answer

Carcinoma of the vulva

Answer

Pelvic radiotherapy

Answer

Carcinoma of the cervix

Answer

Carcinoma of endometrium

Question 7

Which of the following statements about ovarian cysts is FALSE?

Accepted Answer

Follicular cysts are the most common type of functional ovarian cyst.

Answer

Corpus luteum cysts are often associated with pregnancy.

Answer

Dermoid cysts are germ cell tumors.

Answer

Ovarian fibromas are associated with Meigs' syndrome.

Question 8

A woman presents with a histopathology report of endometrial hyperplasia. Which of the following ovarian lesions is NOT a potential cause?

Accepted Answer

Fibroid

Answer

Thecoma

Answer

Brenner tumor

Answer

Follicular cyst

Question 9

A 29-year-old nulliparous woman complains of severe menorrhagia and lower abdominal pain for the past 3 months. On examination, her uterus is enlarged to 14 weeks' size with a fundal fibroid. What is the treatment of choice?

Accepted Answer

Myomectomy

Answer

GnRH analogues

Answer

Hysterectomy

Answer

Wait and watch

Question 10

Decreased vascularity of fibroid is seen with which of the following medications?

Accepted Answer

Clomiphene citrate

Answer

GnRH agonist

Answer

Danazol

Answer

Mifepristone

Gynecological Disorders — MCQs

Gynecological Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?